X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-05-15 | BDX | Becton Dickinson & Co | Goette Roland | EVP, Pres EMEA | S - Sale | $236.74 | -3,300 | 12,493 | -21% | -$781,224 | ||||||
| D | 2024-05-15 | GKOS | Glaukos Corp | Stapley Marc | Dir | S - Sale+OE | $112.80 | -6,250 | 32,360 | -16% | -$704,993 | |||||
2024-05-16 | ICUI | Icu Medical Inc/de | Finney Elisha W | Dir | S - Sale | $104.95 | -300 | 2,129 | -12% | -$31,484 | ||||||
| D | 2024-05-16 | NEPH | Nephros Inc | Banks Robert R. Jr. | Pres, CEO | P - Purchase | $2.24 | +50,000 | 70,000 | +250% | +$112,050 | |||||
2024-05-15 | SYK | Stryker Corp | Boehnlein Glenn S | VP, CFO | S - Sale | $327.65 | -10,000 | 16,556 | -38% | -$3,276,516 | ||||||
2024-05-15 | DXCM | Dexcom Inc | Dolan Matthew Vincent | EVP Strategy, Corporate Dev | S - Sale | $126.58 | -2,423 | 40,075 | -6% | -$306,703 | ||||||
2024-05-15 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.12 | +1,210 | 15,300,113 | 0% | +$1,355 | ||||||
2024-05-13 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $207.41 | -600 | 63,488 | -1% | -$124,447 | ||||||
| D | 2024-05-13 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $45.97 | -6,000 | 182,894 | -3% | -$275,812 | |||||
| M | 2024-05-13 | LMAT | Lemaitre Vascular Inc | Lemaitre George W | COB, CEO | S - Sale | $76.62 | -76,794 | 1,998,334 | -4% | -$5,884,058 | |||||
2024-05-13 | BDX | Becton Dickinson & Co | Goette Roland | EVP, Pres EMEA | S - Sale | $236.70 | -3,300 | 15,793 | -17% | -$781,121 | ||||||
2024-05-13 | CERS | Cerus Corp | Shan Hua | Dir | P - Purchase | $1.99 | +2,500 | 32,386 | +8% | +$4,975 | ||||||
2024-05-14 | TMCI | Treace Medical Concepts, Inc. | Kiernan Jane E | Dir | P - Purchase | $5.17 | +19,356 | 24,941 | +347% | +$100,001 | ||||||
2024-05-14 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $5.12 | +150,000 | 11,567,224 | +1% | +$767,805 | ||||||
| D | 2024-05-10 | GMED | Globus Medical Inc | Lemaitre Dan | Dir | S - Sale+OE | $64.61 | -63,300 | 0 | -100% | -$4,090,022 | |||||
| D | 2024-05-10 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $110.56 | -2,395 | 101,845 | -2% | -$264,791 | |||||
2024-05-10 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $110.51 | -353 | 51,647 | -1% | -$39,011 | ||||||
| M | 2024-05-10 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.09 | +9,360 | 15,298,903 | 0% | +$10,172 | |||||
2024-05-10 | MDAI | Spectral Ai, Inc. | Dimaio John Michael | Dir, 10% | P - Purchase | $1.72 | +6,000 | 2,491,908 | 0% | +$10,320 | ||||||
2024-05-09 | SKWD | Skyward Specialty Insurance Group, Inc. | Westaim Corp | 10% | S - Sale | $36.50 | -5,060,000 | 1,919,639 | -72% | -$184,690,000 | ||||||
2024-05-10 | TMCI | Treace Medical Concepts, Inc. | Jain Deepti | Dir | P - Purchase | $4.50 | +25,000 | 31,235 | +401% | +$112,568 | ||||||
| M | 2024-05-10 | TMCI | Treace Medical Concepts, Inc. | Mott Richard W | Dir | P - Purchase | $4.51 | +120,000 | 1,027,753 | +13% | +$540,939 | |||||
| M | 2024-05-10 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | P - Purchase | $4.54 | +228,000 | 1,595,624 | +17% | +$1,034,004 | |||||
2024-05-10 | TMCI | Treace Medical Concepts, Inc. | Bakewell John K | Dir | P - Purchase | $4.57 | +130,000 | 477,348 | +37% | +$594,620 | ||||||
| M | 2024-05-10 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $4.57 | +300,000 | 11,417,224 | +3% | +$1,370,370 | |||||
2024-05-10 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $23.42 | -1,250 | 167,482 | -1% | -$29,275 | ||||||
2024-05-10 | CERS | Cerus Corp | Nachtsheim Jami K | Dir | P - Purchase | $1.79 | +2,000 | 108,362 | +2% | +$3,578 | ||||||
| D | 2024-05-10 | BSX | Boston Scientific Corp | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale+OE | $74.14 | -12,931 | 31,422 | -29% | -$958,717 | |||||
2024-05-09 | CERS | Cerus Corp | Witney Frank | Dir | P - Purchase | $1.89 | +20,000 | 180,059 | +12% | +$37,800 | ||||||
2024-05-09 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $23.79 | -979 | 168,732 | -1% | -$23,286 | ||||||
2024-05-08 | GMED | Globus Medical Inc | Davidar David D | Dir | S - Sale | $65.00 | -20,000 | 772,242 | -3% | -$1,300,000 | ||||||
2024-05-08 | TCMD | Tactile Systems Technology Inc | Burke William W | Dir | S - Sale | $14.06 | -2,500 | 35,742 | -7% | -$35,150 | ||||||
| D | 2024-05-08 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale+OE | $211.37 | -13,000 | 92,056 | -12% | -$2,747,810 | |||||
2024-05-10 | ICUI | Icu Medical Inc/de | Sousa Ben | CIO | S - Sale | $105.55 | -2,000 | 1,319 | -60% | -$211,090 | ||||||
| D | 2024-05-08 | PSTV | Plus Therapeutics, Inc. | Sims Andrew John Hugh Macintyre | CFO | P - Purchase | $2.04 | +4,902 | 5,717 | +601% | +$10,000 | |||||
| D | 2024-05-08 | PSTV | Plus Therapeutics, Inc. | Hedrick Marc H | CEO | P - Purchase | $2.04 | +12,255 | 12,425 | >999% | +$25,000 | |||||
| D | 2024-05-08 | PSTV | Plus Therapeutics, Inc. | Petersen Greg | Dir | P - Purchase | $2.04 | +12,255 | 36,421 | +51% | +$25,000 | |||||
| D | 2024-05-08 | PSTV | Plus Therapeutics, Inc. | Clowes Howard | Dir | P - Purchase | $2.04 | +9,804 | 21,497 | +84% | +$20,000 | |||||
| D | 2024-05-08 | PSTV | Plus Therapeutics, Inc. | Hawkins Richard J | Dir | P - Purchase | $2.04 | +4,902 | 4,903 | >999% | +$10,000 | |||||
| D | 2024-05-08 | PSTV | Plus Therapeutics, Inc. | Lenk Robert P | Dir | P - Purchase | $2.04 | +4,167 | 29,327 | +17% | +$8,501 | |||||
2024-05-09 | CERS | Cerus Corp | Swisher Daniel N Jr | Dir | P - Purchase | $1.88 | +2,500 | 107,045 | +2% | +$4,689 | ||||||
| D | 2024-05-07 | WST | West Pharmaceutical Services Inc | Green Eric Mark | Pres, CEO, Board Chair | S - Sale+OE | $366.65 | -66,000 | 161,908 | -29% | -$24,199,050 | |||||
| D | 2024-05-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $216.50 | -14,683 | 444,842 | -3% | -$3,178,815 | |||||
2024-05-06 | TCMD | Tactile Systems Technology Inc | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $14.37 | -815 | 62,574 | -1% | -$11,713 | ||||||
| D | 2024-05-06 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $110.36 | -105 | 101,845 | 0% | -$11,588 | |||||
2024-05-06 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $110.26 | -90 | 52,000 | 0% | -$9,923 | ||||||
| M | 2024-05-06 | LMAT | Lemaitre Vascular Inc | Lemaitre George W | COB, CEO | S - Sale | $75.60 | -123,206 | 2,079,128 | -6% | -$9,314,501 | |||||
2024-05-06 | LMAT | Lemaitre Vascular Inc | Roberts David B | Pres, Dir | S - Sale | $75.62 | -5,025 | 14,114 | -26% | -$379,991 | ||||||
2024-05-06 | HAE | Haemonetics Corp | Lingamneni Anila | EVP, CTO | S - Sale | $95.00 | -2,305 | 12,295 | -16% | -$218,975 | ||||||
2024-05-07 | BSX | Boston Scientific Corp | Dockendorff Charles J | Dir | S - Sale | $72.70 | -3,946 | 60,002 | -6% | -$286,874 | ||||||
2024-05-06 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.09 | +4,240 | 15,289,543 | 0% | +$4,622 | ||||||
2024-05-02 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $105.69 | -442 | 52,090 | -1% | -$46,713 | ||||||
| D | 2024-05-02 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $105.52 | -2,059 | 101,845 | -2% | -$217,263 | |||||
2024-05-01 | PRCT | Procept Biorobotics Corp | Krummel Thomas M | Dir | S - Sale | $60.00 | -20,000 | 45,631 | -30% | -$1,200,000 | ||||||
| D | 2024-05-03 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale+OE | $62.97 | -30,432 | 62,472 | -33% | -$1,916,428 | |||||
| D | 2024-05-01 | UBI | Universal Biosensors Inc | Coleman Craig E. | Dir, 10% | P - Purchase | $0.15 | +29,506,606 | 87,058,827 | +51% | +$4,425,991 | |||||
2024-05-01 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $42.00 | -38,549 | 965,359 | -4% | -$1,619,047 | ||||||
| M | 2024-05-01 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $14.02 | -29,206 | 3,406,335 | -1% | -$409,426 | |||||
2024-05-01 | ATRC | Atricure, Inc. | Noznesky Justin J | Chief Mktg, Strategy Officer | S - Sale | $24.09 | -1,500 | 71,284 | -2% | -$36,135 | ||||||
2024-04-30 | DXCM | Dexcom Inc | Brown Michael Jon | EVP GC | S - Sale | $126.25 | -629 | 68,212 | -1% | -$79,411 | ||||||
| D | 2024-05-01 | BSX | Boston Scientific Corp | Sorenson John Bradley | EVP, Global Operations | S - Sale+OE | $71.50 | -17,587 | 50,638 | -26% | -$1,257,488 | |||||
| D | 2024-05-01 | BSX | Boston Scientific Corp | Carruthers Wendy | EVP, HR | S - Sale+OE | $71.47 | -6,983 | 48,348 | -13% | -$499,075 | |||||
2024-05-02 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $14.54 | -343 | 123,765 | 0% | -$4,986 | ||||||
2024-04-30 | BDX | Becton Dickinson & Co | Garrison Michael David | EVP, Pres Medical | S - Sale | $232.81 | -1,715 | 5,381 | -24% | -$399,269 | ||||||
| A | 2024-04-22 | NURO | Neurometrix, Inc. | Horowitz Joshua | Dir | S - Sale | $4.58 | -1,000 | 83,938 | -1% | -$4,580 | |||||
2024-04-29 | RMD | Resmed Inc | Drexler Karen | Dir | S - Sale | $214.92 | -425 | 8,446 | -5% | -$91,341 | ||||||
| D | 2024-04-26 | BSX | Boston Scientific Corp | Ludwig Edward J | Dir | S - Sale+OE | $73.29 | -9,818 | 41,374 | -19% | -$719,562 | |||||
| M | 2024-04-25 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.07 | +872 | 15,285,303 | 0% | +$932 | |||||
2024-04-24 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $14.06 | -1,781 | 3,435,541 | 0% | -$25,041 | ||||||
2024-04-24 | ATEC | Alphatec Holdings, Inc. | Koning John Todd | CFO | S - Sale | $12.82 | -37,500 | 393,356 | -9% | -$480,750 | ||||||
2024-04-22 | GCTK | Glucotrack, Inc. | Sycoff Drew | Dir, 10% | P - Purchase | $1.26 | +182,540 | 2,951,258 | +7% | +$230,000 | ||||||
2024-04-22 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $7.49 | -1,184 | 306,684 | 0% | -$8,868 | ||||||
| M | 2024-04-19 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $14.12 | -64,653 | 3,437,322 | -2% | -$913,057 | |||||
2024-04-16 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $40.00 | -1,451 | 999,782 | 0% | -$58,040 | ||||||
| M | 2024-04-16 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $14.02 | -16,992 | 3,501,975 | 0% | -$238,231 | |||||
2024-04-17 | INSP | Inspire Medical Systems, Inc. | Buchholz Richard | CFO | S - Sale | $230.03 | -15,000 | 30,471 | -33% | -$3,450,450 | ||||||
2024-04-17 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.03 | +15,363 | 15,284,431 | 0% | +$15,801 | ||||||
2024-04-15 | PETV | Petvivo Holdings, Inc. | Lai John | CEO, Pres | P - Purchase | $0.60 | +150,000 | 1,288,592 | +13% | +$90,000 | ||||||
| D | 2024-04-12 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $40.96 | -6,000 | 182,894 | -3% | -$245,760 | |||||
2024-04-15 | DXCM | Dexcom Inc | Dolan Matthew Vincent | EVP Strategy, Corporate Dev | S - Sale | $137.81 | -1,990 | 42,377 | -4% | -$274,242 | ||||||
2024-04-15 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.06 | +3,587 | 15,269,068 | 0% | +$3,802 | ||||||
2024-04-11 | BVS | Bioventus Inc. | Singleton Mark Leonard | SVP, CFO | S - Sale | $4.75 | -4,000 | 34,665 | -10% | -$19,000 | ||||||
2024-04-11 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $4.75 | -3,054 | 58,242 | -5% | -$14,507 | ||||||
2024-04-11 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $4.75 | -1,325 | 17,042 | -7% | -$6,294 | ||||||
| M | 2024-04-11 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $14.49 | -485,000 | 3,518,967 | -12% | -$7,026,033 | |||||
| D | 2024-04-08 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $100.47 | -59,801 | 101,845 | -37% | -$6,008,359 | |||||
2024-04-08 | DXCM | Dexcom Inc | Sayer Kevin R | Pres CEO, COB | S - Sale | $138.30 | -49,633 | 283,893 | -15% | -$6,864,136 | ||||||
| M | 2024-04-05 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $99.91 | -1,634 | 52,532 | -3% | -$163,260 | |||||
| D | 2024-04-05 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $96.81 | -2,457 | 101,845 | -2% | -$237,862 | |||||
2024-04-08 | ANGO | Angiodynamics Inc | Clemmer James C | Pres, CEO | P - Purchase | $6.70 | +10,000 | 539,066 | +2% | +$67,000 | ||||||
| M | 2024-04-02 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.10 | +42,044 | 15,265,481 | 0% | +$46,383 | |||||
| DM | 2024-04-03 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $96.59 | -400 | 101,845 | 0% | -$38,636 | |||||
| M | 2024-04-03 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $95.03 | -750 | 54,166 | -1% | -$71,271 | |||||
| M | 2024-04-02 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $15.53 | -4,227 | 251,533 | -2% | -$65,652 | |||||
2024-04-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $15.45 | -2,425 | 205,516 | -1% | -$37,474 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $5.08 | -4,893 | 168,620 | -3% | -$24,852 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO | S - Sale | $5.08 | -12,571 | 5,750,729 | 0% | -$63,848 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $5.08 | -3,128 | 1,762,776 | 0% | -$15,887 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Park Sam Boong | COO | S - Sale | $5.08 | -3,414 | 261,754 | -1% | -$17,340 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $5.08 | -10,123 | 426,248 | -2% | -$51,415 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |